Hyperconcentrated Mucus Unifies Submucosal Gland and Superficial Airway Dysfunction in Cystic Fibrosis
Kato, T.; Radicioni, G.; Papanikolas, M. J.; Stoychev, G. V.; Markovetz, M. R.; Aoki, K.; Porterfield, M.; Okuda, K.; Cardenas, S. M. B.; Gilmore, R. C.; Morrison, C. B.; Ehre, C.; Burns, K. A.; White, K. K.; Goodell, H. P.; Thacker, H.; Loznev, H. T.; Forsberg, L. J.; Nagase, T.; Rubinstein, M.; Randell, S. H.; Tiemeyer, M.; Hill, D. B.; Kesimer, M.; O'Neal, W. K.; Ballard, S. T.; Freeman, R.; Button, B.; Boucher, R. C.
Show abstract
Cystic fibrosis (CF) is characterized by abnormal transepithelial ion transport. However, a description of CF lung disease pathophysiology unifying superficial epithelial and submucosal gland (SMG) dysfunctions has remained elusive. We hypothesized that biophysical abnormalities associated with CF mucus hyperconcentration provide a unifying mechanism. Studies of the anion secretion-inhibited pig airway CF model revealed elevated SMG mucus concentrations, osmotic pressures, and SMG mucus accumulation. Human airway studies revealed hyperconcentrated CF SMG mucus with raised osmotic pressures and cohesive forces predicted to limit SMG mucus secretion/release. Utilizing proline-rich protein 4 (PRR4) as a biomarker of SMG secretion, proteomics analyses of CF sputum revealed markedly lower PRR4 levels compared to healthy and bronchiectasis controls, consistent with a failure of CF SMGs to secrete mucus onto airway surfaces. Raised mucus osmotic/cohesive forces, reflecting mucus hyperconcentration, provide a unifying mechanism that describes disease-initiating mucus accumulation on airway surfaces and within SMGs of the CF lung.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.